Bone Density & Osteoporosis
Calcium and Vitamin D for Bone Health
Calcium and vitamin D are essential nutrients, but a 2026 review found little to no fracture-prevention benefit from routine supplements in most adults studied.
Calcium and vitamin D are probably the most familiar bone supplements, often taken together from midlife on as a kind of insurance. Humanic Blue looks at who was studied, because a supplement that helps someone with low nutrient intake may not help someone whose needs are already met.
Your bones need calcium and vitamin D, but taking extra is not the same as preventing a fracture. A 2026 systematic review of 69 randomized trials found little to no clinically meaningful fracture or falls benefit from calcium, vitamin D or the combination in the populations studied. Most participants lived in the community and were not at high fracture or falls risk; evidence was limited for residential-care and some high-risk groups. The US Preventive Services Task Force (USPSTF) 2024 draft, still in progress as of September 29, 2026, likewise separates routine prevention from treatment for osteoporosis or deficiency. For living longer and better, the question is whether supplements fill a documented need—not whether every older adult should take them.
Key Takeaways
- Across 69 randomized trials, calcium, vitamin D and combined supplements produced little to no meaningful fracture or falls benefit in the populations studied. Evidence was generally moderate to high certainty, but limited for some high-risk groups.
- One trial in women averaging 84 who lived in residential care found fewer hip fractures with combined supplements. Many women did not finish the study, and the result does not apply automatically to healthier adults living at home.
- The Women’s Health Initiative (WHI) trial found more kidney stones with combined calcium and vitamin D. The 17% increase was relative to the comparison group, not 17 extra cases in every 100 women.
- People with osteoporosis, a past osteoporotic fracture or vitamin D deficiency are outside the USPSTF prevention draft.
- These fracture-prevention trials do not establish longer life.
What do bones need from calcium and vitamin D?
The NIH Office of Dietary Supplements lists recommended intakes for calcium and vitamin D from food, drinks and supplements combined. Calcium needs rise at 51 for women and at 71 for men; vitamin D recommendations rise at 71 for both. The age-by-age amounts are in the resources below.
These are total-intake goals, not amounts to add on top of your diet. The calcium upper limit for adults 51 and older is 2,000 milligrams (mg) a day from all sources. It is not a target or a guarantee of safety for someone with kidney disease, kidney stones or other individual risks.
Do supplements prevent fractures in healthy adults at home?
The Women’s Health Initiative. In this trial of postmenopausal women, combined calcium and vitamin D slightly improved hip bone density without significantly reducing hip fractures overall. Kidney stones increased. A secondary analysis of women who kept taking the pills suggested a fracture benefit, but could not exclude differences between women who did and didn’t stay on treatment.
VITAL. An analysis of the VITAL trial found no reduction in total fractures, fractures outside the spine or hip fractures with daily vitamin D3. Researchers did not recruit participants specifically because they had vitamin D deficiency, low bone mass or osteoporosis, so the result does not answer how to treat those conditions.
The pooled evidence. A 2017 JAMA meta-analysis combining results from 33 trials in adults over 50 living at home found no significant association between calcium, vitamin D or both and hip fracture. The larger 2026 BMJ review incorporated 69 trials in adults not receiving drug treatment for osteoporosis. It found little to no clinically meaningful benefit for fracture or falls outcomes, based largely on moderate- to high-certainty evidence.
Very old, likely deficient: a different result
A 1992 French trial studied women who could walk and lived in nursing homes or apartment homes for older people. They averaged 84 years old and had low calcium intake. Combined calcium and vitamin D reduced hip fractures and fractures outside the spine among women who finished the study; the paper reported similar results when all women were analyzed in their originally assigned groups.
Only a little over half completed the 18-month study because of deaths and other withdrawals. Vitamin D levels in the placebo group remained low. Those starting conditions—and the many withdrawals—matter when comparing this result with trials in generally healthy adults living at home. Exact doses and results appear below.
The USPSTF draft doesn’t apply to people living in nursing homes or other institutions, or to anyone with osteoporosis, a past fracture or vitamin D deficiency.
How does the French trial population change the question about calcium and vitamin D supplements?
Why did older reviews disagree?
A 2019 meta-analysis in JAMA Network Open separated trials by what people took and how often. Vitamin D alone, daily or intermittently, did not clearly reduce fractures. Six trials of daily vitamin D with calcium found modestly lower fracture risk relative to the comparison groups. The exact doses and estimates are below.
The 2026 review evaluated absolute as well as relative effects and applied thresholds for clinical importance. Combined supplementation slightly lowered the risk of any fracture relative to the comparison groups, but the actual difference in how many people fractured was too small to meet the reviewers’ threshold for a meaningful benefit. They found little to no effect on other fracture and falls outcomes. Its extensive subgroup analyses did not produce a robust reason to prescribe routine supplements broadly, but evidence remained limited for residential-care residents and some high-risk groups. Relative effects describe the change compared with the starting risk; absolute effects describe how many more or fewer people are affected. A percentage reduction can look substantial while helping few people if few would have fractured anyway.
Which differences in supplement schedules and living arrangements might account for the reviews' different findings?
What the guidance says now
The USPSTF’s 2018 recommendation remains final. For routine fracture prevention in postmenopausal women living at home, it recommends against daily supplementation with 400 international units (IU) or less of vitamin D and 1,000 mg or less of calcium, and finds evidence insufficient for higher doses and for men.
The December 2024 draft goes further: it advises against routine vitamin D, alone or with calcium, to prevent falls and fractures in community-dwelling postmenopausal women and men age 60 or older. The USPSTF update page still labels it in progress as of September 29, 2026, so it is not final guidance. Both the final and draft documents exclude treatment for osteoporosis, a history of osteoporotic fractures or vitamin D deficiency.
Vitamin D’s separate record on falls, mortality and large annual doses is covered in Vitamin D and Longevity.
What’s Interesting
The same two nutrients produced a large hip-fracture result in one institutional trial and little to no clinically meaningful benefit across the much larger 2026 synthesis. The older trial enrolled women averaging 84 with low calcium intake and persistently low vitamin D in the placebo group, while most participants in the later evidence base lived in the community and were not at high risk. Population and baseline need matter, and evidence for some high-risk groups remains limited.
What This Means in Practice
For living longer and better, nutritional adequacy and fracture prevention are different questions. The NIH intake figures describe total nutrient needs in generally healthy people. The USPSTF documents ask whether routinely adding pills prevents fractures or falls; they do not set treatment for osteoporosis or deficiency.
A useful clinical discussion can separate total intake from food and supplements, any diagnosed deficiency, fracture history and kidney-stone risk. Those details explain why a prevention-trial result may not answer an individual treatment question. Exercise and fall prevention have their own evidence, described in How Can Older Adults Prevent Falls? and Strength Training for Bone Health.
A primary care clinician can check fracture risk and vitamin D if there’s a reason to test. A registered dietitian can help you reach calcium targets through food.
Bottom Line
Calcium and vitamin D are essential nutrients, but the 2026 review of 69 randomized trials found little to no clinically meaningful fracture or falls benefit from routine supplements in the populations studied. The WHI also found more kidney stones. A 1992 trial in institutionalized women averaging 84 had a different result, but many women did not complete it, and its result cannot be generalized to every adult after midlife. The USPSTF’s draft remains unfinalized and addresses routine prevention, not treatment for osteoporosis or deficiency. NIH intake targets and a clinician’s assessment of a documented gap address nutritional needs; routine fracture prevention is a separate claim. These trials do not establish longer life.
A NOTE FROM LONGEVITY365
We read research, consult expert perspectives and work to make complicated health information easier to understand. What you’re reading here reflects how we’ve interpreted and organized that information. It is educational content—not personal medical advice, diagnosis or treatment guidance.
We’re not perfect, and neither is the available research. Evidence changes, new studies emerge and what’s appropriate for one person may not be appropriate for another.
Use this article as a starting point for your own research and conversations with qualified professionals. Always talk with your doctor or another trusted healthcare professional before making decisions that could affect your health, particularly if you take medications, are receiving treatment, have existing health conditions, are pregnant or have other circumstances that could affect what’s appropriate for you.
Reader Questions
A few questions to carry into the comments or your next conversation. Please leave out identifying or personal medical details.
- 01What would you want to know before putting "Calcium and Vitamin D for Bone Health" into the same conversation as sleep, food, movement, and medical care?
- 02Which evidence boundary stood out most: lifespan, function, symptoms, biomarkers, dose, safety, or who was actually studied?
- 03What question would help keep a supplement conversation grounded instead of turning it into a shopping list?
Extra Insights & Sources
The evidence summaries and linked sources behind this article.
What We Know
- Calcium and vitamin D are needed for bone; calcium recommendations rise at 51 for women and 71 for men, and vitamin D recommendations at 71. Established.
- Across 69 randomized trials, supplements produced little to no clinically meaningful fracture or falls benefit in the populations studied. Moderate-to-high-certainty synthesis for most outcomes.
- In one trial of institutionalized women averaging 84, calcium and vitamin D produced 43% fewer hip fractures among completers, with similar findings reported when women were kept in their originally assigned groups. Population-specific; 54% completed 18 months.
- Calcium plus vitamin D increased kidney stones by 17% in the WHI. Supported.
What We Don’t Know
- Whether particular high-risk or residential-care populations benefit meaningfully. Evidence was limited for several such comparisons in the 2026 review. Uncertain.
- How much any benefit depends on a documented starting deficiency or low intake. Uncertain.
- Whether these supplements affect lifespan. Unknown. Fracture trials weren’t designed to measure it.
- Whether the USPSTF draft will be finalized unchanged. It remained in progress on September 29, 2026. Uncertain.
Daily intake reference
Recommended totals from the NIH Office of Dietary Supplements’ calcium and vitamin D fact sheets:
| Age | Calcium | Vitamin D |
|---|---|---|
| 19–50 | 1,000 mg | 600 IU |
| Men 51–70 | 1,000 mg | 600 IU |
| Women 51–70 | 1,200 mg | 600 IU |
| Over 70 | 1,200 mg | 800 IU |
These are daily totals from food, drinks and supplements, not supplement doses. Mg means milligrams; IU means international units, a measure of vitamin D activity. The figures apply to generally healthy adults and are not a deficiency-treatment plan.
Trial details
- WHI: 36,282 postmenopausal women aged 50–79; 1,000 mg calcium plus 400 IU vitamin D daily versus placebo for about seven years. Hip bone density was 1.06% higher, but the hip-fracture hazard ratio of 0.88 was not statistically significant. Kidney stones increased by 17% relatively. The hip-fracture hazard ratio was 0.71 among women who kept taking the pills. A hazard ratio compares event rates over follow-up: 1 means no difference, and a value below 1 favors supplements. The overall 0.88 result could not reliably distinguish benefit from chance. Comparing women by whether they kept taking pills can mix treatment effects with other differences between those women.
- VITAL: 25,871 US adults; 2,000 IU vitamin D3 daily versus placebo; median follow-up 5.3 years. No reduction in the fracture outcomes tested. This was not a deficiency-treatment trial.
Source Materials
- Dionne et al. — Calcium, vitamin D or combined supplementation to prevent fractures and falls — 2026 systematic review and meta-analysis of 69 randomized trials and 153,902 adults not receiving osteoporosis drug treatment. Supports the current little-to-no-clinically-meaningful-benefit conclusion, regimen-specific estimates, certainty ratings and high-risk/residential-care evidence gaps. Most participants were community dwelling and not at high fracture or falls risk.
- Women’s Health Initiative calcium/vitamin D trial — Randomized trial of 36,282 postmenopausal women ages 50–79, using 1,000 mg calcium plus 400 IU vitamin D daily for an average seven years. Supports the bone mineral density (BMD), fracture and kidney-stone results. Personal calcium/vitamin D use and osteoporosis medicines were permitted, and adherence-based analyses do not preserve the full protection of randomization.
- LeBoff et al. — VITAL fracture analysis — Randomized trial of 25,871 U.S. adults receiving 2,000 IU vitamin D3 daily or placebo for a median 5.3 years. Supports the finding of no clear benefit for total fractures, fractures outside the spine and hip fractures. Participants were not selected for deficiency, low BMD or osteoporosis, so it is not a treatment trial for those conditions.
- Zhao et al. — Calcium/vitamin D and fractures in community-dwelling older adults — 2017 meta-analysis of 33 randomized trials and 51,145 adults over 50. Supports the earlier finding of no clear fracture benefit in adults living at home. It predates later trials incorporated in the 2026 review.
- Chapuy et al. — Vitamin D3 and calcium in institutionalized older women — 1992 controlled trial of 3,270 ambulatory women ages 69–106 living in 180 nursing homes or apartment homes for older people. Supports the population, dose, 18-month fracture results and biochemical findings. Only 1,765 women (54%) completed the full follow-up. Daily doses were 1,200 mg calcium and 800 IU vitamin D3 versus placebo for 18 months. Among completers, hip fractures were 43% lower and fractures outside the spine 32% lower relative to placebo; the paper reported similar results when women were kept in their originally assigned groups, whether or not they completed treatment. The setting, low calcium intake and low vitamin D status limit application to other populations.
- Yao et al. — Vitamin D and calcium fracture meta-analysis — 2019 synthesis supporting the prior regimen-specific relative estimates for vitamin D alone and daily combined supplements. Residence was not restricted as in the 2017 community-only review; the newer 2026 synthesis interprets absolute clinical importance across a larger evidence base. The 2019 combined-supplement estimates came from six trials with 49,282 people taking 400–800 IU vitamin D and 1,000–1,200 mg calcium daily: relative risk was 6% lower for any fracture and 16% lower for hip fracture. In 2026, the any-fracture risk ratio was 0.91 across 15 combination trials (51,126 participants), equivalent to a 9% relative reduction, but the reviewers judged the absolute benefit little to none.
- USPSTF — 2024 draft recommendation — Draft position against routine vitamin D, alone or combined with calcium, for primary prevention of falls and fractures in community-dwelling postmenopausal women and men age 60 or older. It excludes osteoporosis, osteoporotic fracture and vitamin D deficiency and remained an update in progress on September 29, 2026; it is not final guidance.
- USPSTF — 2018 final recommendation — Current final U.S. preventive recommendation: recommends against 400 IU or less vitamin D plus 1,000 mg or less calcium in community-dwelling postmenopausal women and finds evidence insufficient for higher doses and other adult groups. It addresses primary prevention, not treatment.
- NIH Office of Dietary Supplements — Calcium — Federal professional fact sheet supporting age- and sex-specific recommended total intakes and the 2,000-mg adult upper limit after age 50. The upper limit is not a target and does not determine individual safety.
- NIH Office of Dietary Supplements — Vitamin D — Federal professional fact sheet supporting recommended total vitamin D intakes by age. Dietary reference intakes apply to generally healthy people and are not a treatment protocol for deficiency.
Related product and service comparisons
The companion comparison describes the nutrients, serving amounts and ingredient differences on named calcium and vitamin D labels.
Photo credits
Images from Pexels.
- featured: Photo by Antoni Shkraba — original Pexels photo.
- inline-1: Photo by Jsme MILA — original Pexels photo.
- inline-2: Photo by Vitaly Gariev — original Pexels photo.
Leave a Reply